In vivo analgesic and anti-inflammatory activities of Rosmarinus officinalis aqueous extracts, rosmarinic acid and its acetyl ester derivative. (September 2013)
- Record Type:
- Journal Article
- Title:
- In vivo analgesic and anti-inflammatory activities of Rosmarinus officinalis aqueous extracts, rosmarinic acid and its acetyl ester derivative. (September 2013)
- Main Title:
- In vivo analgesic and anti-inflammatory activities of Rosmarinus officinalis aqueous extracts, rosmarinic acid and its acetyl ester derivative
- Authors:
- Lucarini, Rodrigo
Bernardes, Wagner A.
Ferreira, Daniele S.
Tozatti, Marcos G.
Furtado, Ricardo
Bastos, Jairo K.
Pauletti, Patrícia M.
Januário, Ana H.
Silva, Márcio L. Andrade e
Cunha, Wilson R. - Abstract:
- <abstract> <title>Abstract</title> <p> <italic>Context</italic>: Despite several pharmacological applications of <italic>Rosmarinus officinalis</italic> L. (Lamiaceae), studies on its analgesic and anti-inflammatory properties have been scarce.</p> <p> <italic>Objective</italic>: The aim of this work was to use <italic>in vivo</italic> models to evaluate the analgesic and anti-inflammatory activities of the aqueous extracts obtained from leaves (AEL) and stems (AES) of <italic>Rosmarinus officinalis, </italic> as well as its isolated compound – rosmarinic acid (RA). We also prepared and assessed the acetyl ester derivative of RA.</p> <p> <italic>Materials and methods</italic>: The analgesic activity was evaluated using abdominal constriction and formalin tests. For the evaluation of the anti-inflammatory effects, carrageenin-induced paw edema in rats were used. The extracts were used at doses of 100, 200 and 400 mg kg<sup>−1</sup> compounds were tested at 10, 20 and 40 mg kg<sup>−1</sup>.</p> <p> <italic>Results</italic>: Orally administered AEL, AES and RA were not significantly active at any of the doses tested during the abdominal constriction test; the acetyl ester derivative of RA displayed significant analgesic activity. In the carrageenin-induced paw edema assay, the acetyl derivative of RA at all the tested doses produced significant anti-inflammatory effects and reduced the number of paw licks in the second phase of the formalin test.</p> <p> <italic>Discussion and<abstract> <title>Abstract</title> <p> <italic>Context</italic>: Despite several pharmacological applications of <italic>Rosmarinus officinalis</italic> L. (Lamiaceae), studies on its analgesic and anti-inflammatory properties have been scarce.</p> <p> <italic>Objective</italic>: The aim of this work was to use <italic>in vivo</italic> models to evaluate the analgesic and anti-inflammatory activities of the aqueous extracts obtained from leaves (AEL) and stems (AES) of <italic>Rosmarinus officinalis, </italic> as well as its isolated compound – rosmarinic acid (RA). We also prepared and assessed the acetyl ester derivative of RA.</p> <p> <italic>Materials and methods</italic>: The analgesic activity was evaluated using abdominal constriction and formalin tests. For the evaluation of the anti-inflammatory effects, carrageenin-induced paw edema in rats were used. The extracts were used at doses of 100, 200 and 400 mg kg<sup>−1</sup> compounds were tested at 10, 20 and 40 mg kg<sup>−1</sup>.</p> <p> <italic>Results</italic>: Orally administered AEL, AES and RA were not significantly active at any of the doses tested during the abdominal constriction test; the acetyl ester derivative of RA displayed significant analgesic activity. In the carrageenin-induced paw edema assay, the acetyl derivative of RA at all the tested doses produced significant anti-inflammatory effects and reduced the number of paw licks in the second phase of the formalin test.</p> <p> <italic>Discussion and conclusion</italic>: The results suggest that the analgesic effects of the acetyl derivative of RA operate via a peripheral-mediated mechanism. The acetyl ester derivative of RA is potentially applicable as a new lead compound for the management of pain and inflammation.</p> </abstract> … (more)
- Is Part Of:
- Pharmaceutical biology. Volume 51:Number 9(2013:Sep.)
- Journal:
- Pharmaceutical biology
- Issue:
- Volume 51:Number 9(2013:Sep.)
- Issue Display:
- Volume 51, Issue 9 (2013)
- Year:
- 2013
- Volume:
- 51
- Issue:
- 9
- Issue Sort Value:
- 2013-0051-0009-0000
- Page Start:
- 1087
- Page End:
- 1090
- Publication Date:
- 2013-09
- Subjects:
- Pharmacognosy -- Periodicals
Materia medica, Vegetable -- Periodicals
615.321 - Journal URLs:
- http://www.tandfonline.com/toc/iphb20/current ↗
http://informahealthcare.com/journal/phb ↗
http://informahealthcare.com ↗ - DOI:
- 10.3109/13880209.2013.776613 ↗
- Languages:
- English
- ISSNs:
- 1388-0209
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6442.767000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3135.xml